Esperion Therapeutics, Inc. financial data

Symbol
ESPR on Nasdaq
Location
Ann Arbor, MI
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 121% % -33%
Quick Ratio 35% % -21%
Debt-to-equity -193% % 3%
Return On Equity 5.6% % -62%
Return On Assets -6% % 60%
Operating Margin 15% % -8.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 256,810,482 shares 30%
Entity Public Float $198,200,000 USD -54%
Common Stock, Value, Issued $245,000 USD 25%
Weighted Average Number of Shares Outstanding, Basic 207,865,080 shares 11%
Weighted Average Number of Shares Outstanding, Diluted 207,865,080 shares 11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $403,135,000 USD 21%
Operating Income (Loss) $60,273,000 USD 11%
Income Tax Expense (Benefit) $1,841,000 USD
Net Income (Loss) Attributable to Parent $22,682,000 USD 56%
Earnings Per Share, Basic -0.11 USD/shares 61%
Earnings Per Share, Diluted -0.11 USD/shares 61%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $167,852,000 USD 16%
Accounts Receivable, after Allowance for Credit Loss, Current $140,190,000 USD 75%
Inventory, Net $105,124,000 USD 11%
Assets, Current $462,570,000 USD 37%
Property, Plant and Equipment, Net $338,000 USD 33%
Operating Lease, Right-of-Use Asset $2,922,000 USD -47%
Assets $465,886,000 USD 36%
Accounts Payable, Current $65,068,000 USD 26%
Employee-related Liabilities, Current $11,940,000 USD -6.3%
Contract with Customer, Liability, Current $34,477,000 USD 305%
Liabilities, Current $300,810,000 USD 22%
Operating Lease, Liability, Noncurrent $653,000 USD -75%
Other Liabilities, Noncurrent $8,739,000 USD
Liabilities $767,851,000 USD 4.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD
Retained Earnings (Accumulated Deficit) $1,623,711,000 USD -1.4%
Stockholders' Equity Attributable to Parent $301,965,000 USD 22%
Liabilities and Equity $465,886,000 USD 36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $22,628,000 USD -142%
Net Cash Provided by (Used in) Financing Activities $7,500,000 USD -108%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 480,000,000 shares 0%
Common Stock, Shares, Issued 247,210,341 shares 25%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $30,128,000 USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $167,852,000 USD 16%
Deferred Tax Assets, Valuation Allowance $417,064,000 USD 0.96%
Deferred Tax Assets, Gross $417,851,000 USD 0.78%
Operating Lease, Liability $2,755,000 USD -48%
Depreciation $26,000 USD
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $22,682,000 USD 56%
Lessee, Operating Lease, Liability, to be Paid $2,911,000 USD -49%
Property, Plant and Equipment, Gross $2,517,000 USD 8.1%
Operating Lease, Liability, Current $2,102,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Two $440,000 USD -81%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,213,000 USD -28%
Operating Lease, Weighted Average Discount Rate, Percent 0.076 pure 2.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $156,000 USD -65%
Lessee, Operating Lease, Liability, to be Paid, Year Three $258,000 USD 7.1%
Deferred Tax Assets, Operating Loss Carryforwards $211,531,000 USD 3.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $3,402,000 USD 62%
Lessee, Operating Lease, Liability, to be Paid, Year Four $0 USD -100%
Additional Paid in Capital $1,376,499,000 USD 8.6%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $9,870,000 USD -18%
Interest Expense $58,613,000 USD 2.6%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%